Status:

NOT_YET_RECRUITING

The PAPYRUS Study: Permanent vs. Absorbable Sutures in PrimarY Repair of Umbilical HerniaS: A Multicentre, Single-blind, Non-inferiority, Randomized Controlled Trial

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

North York General Hospital

Royal Victoria Hospital Of Barrie

Conditions:

Hernia Surgery

Umbilical Hernia Repair

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Umbilical hernias can be found in over a quarter of the population and comprise of 15% of hernia repairs performed in Canada. While mesh repair is commonly used for larger hernias, smaller hernia defe...

Detailed Description

Umbilical hernias make up a notable proportion of abdominal wall hernia repairs annually. Up to 25% of the population have asymptomatic umbilical hernias when examined using ultrasound. Recent compute...

Eligibility Criteria

Inclusion

  • Elective surgery for primary umbilical hernia with a defect ≤ 2 cm measured clinically or radiographically
  • Age 19 years or older
  • Patient able to give oral and written informed consent

Exclusion

  • Umbilical hernia defect \> 2 cm measured clinically, radiologically, or intraoperatively with ruler
  • Multiple defects
  • Incisional hernia: prior hernia in area of operation
  • Recurrent umbilical hernia
  • Epigastric hernia
  • Secondary operation performed simultaneously
  • Pregnancy
  • Infected wounds
  • Acute operation (incarcerated or strangulated hernia)
  • BMI ≥ 35 kg/m\^2
  • Ascites or liver cirrhosis
  • Peritoneal dialysis
  • Immunosuppression
  • Connective tissue disorder
  • Patient deemed unfit for primary repair at time of surgery based on surgeon discretion at time of operation (e.g. poor tissue quality or unexpected operative finding)
  • Defect is made in the umbilical skin or skin incision extended beyond paraumbilical incision (e.g. sigma or midline extended incision)

Key Trial Info

Start Date :

January 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2030

Estimated Enrollment :

914 Patients enrolled

Trial Details

Trial ID

NCT07156188

Start Date

January 1 2026

End Date

December 31 2030

Last Update

September 30 2025

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Royal Alexandra Hospital/University of Alberta

Edmonton, Alberta, Canada

2

Royal Victoria Hospital

Barrie, Ontario, Canada

3

London Health Sciences Centre

London, Ontario, Canada

4

North York General Hospital

North York, Ontario, Canada